Researcher
Sigrid Stroobants
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Biomarker evaluation, Nuclear imaging, Neurosciences not elsewhere classified
Affiliations
- Molecular Imaging and Radiology (MIRA) (Research group)
Responsible
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Sep 2008 → 31 Dec 2018
Infrastructure
1 - 1 of 1
- Flanders BioImaging (FBI/EBI) (Consortium partner)
Projects
1 - 10 of 29
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Diagnostic and theranostic targeting of fibroblast activation protein (FAP) with goed nanoparticles decorated with FAPIs and FAPI fragments.From1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Development of theranostic ligands for fibroblast activation protein with improved pharmacokinetic profile.From1 Sep 2022 → 31 Aug 2023Funding: IOF - technology validation in lab
- Biomarker and therapy development through in vivo Molecular Imaging of small animals.From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Validation of autophagy induction as a therapeutic strategy: from drug discovery and preclinical evaluation to safety investigation and biomarker research.From1 Jan 2021 → TodayFunding: BOF - projects
- Positron emission tomography combined with innovative laboratory techniques for improved risk and disease assessment in myeloma.From1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Improved PET probes for predicting and imaging immunotherapy responses.From1 Oct 2020 → 30 Sep 2023Funding: FWO senior postdoctoral fellowship
- Biopharmaceutical optimization of PET-diagnostic tools targeting fibroblast activation protein (FAP).From1 May 2020 → 30 Sep 2021Funding: IOF - technology validation in lab
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
Publications
131 - 140 of 155
- Additional value of PET-CT in staging of clinical stage IIB and III breast cancer(2010)
Authors: Isabelle Segaert, Felix Mottaghy, Sarah Ceyssens, Sigrid Stroobants, et al.
Pages: 617 - 624 - FDG PET and PET/CT(2010)
Authors: Ronald Boellaard, Mike J. O'Doherty, Wolfgang A. Weber, Sigrid Stroobants, et al.
Pages: 181 - 200 - Site-specific labeling of second generation annexin V with $^{99m}Tc(CO)_{3}$ for improved imaging of apoptosis in vivo(2010)
Authors: Marijke De Saint-Hubert, Felix M. Mottaghy, Kathleen Vunckx, Sigrid Stroobants, et al.
Pages: 1356 - 1363 - Added value of baseline $^{18}F-FDG$ uptake in serial $^{18}F-FDG$ PET for evaluation of response of solid extracerebral tumors to systemic cytotoxic neoadjuvant treatment: a meta-analysis(2010)
Authors: Henriette M.E. Quarles van Ufford, Harm van Tinteren, Sigrid Stroobants, Ingrid I. Riphagen, Otto S. Hoekstra
Pages: 1507 - 1516 - Impact of FDG-PET-induced treatment choices on long-term outcome in non-small cell lung cancer(2010)
Authors: Isabelle Wauters, Sigrid Stroobants, Paul De Leyn, Isabelle D' Hoore, Kris Nackaerts, Christophe Dooms, Johan Vansteenkiste
Pages: 97 - 104 - FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome(2009)
Authors: Maroun Karam, Ashar Ata, Kevin Irish, Sigrid Stroobants, et al.
Pages: 770 - 778 - Performance of MAP reconstruction for hot lesion detection in whole-body PET/CT(2009)
Authors: J. Nuyts, C. Michel, L. Brepoels, L. De Ceuninck, C. Deroose, K. Goffin, F.M. Mottaghy, Sigrid Stroobants, J. Van Riet, R. Verscuren
Pages: 782 - 790 - Association between 18F-fluoro-2-deoxy-d-glucose uptake values and tumor vitality(2009)
Authors: Christophe Dooms, Angela van Baardwijk, Eric Verbeken, Robert Jan van Suylen, Sigrid Stroobants, Dirk De Ruysscher, Johan Vansteenkiste
Pages: 822 - 828 - $^{18}F-FDG$ and $^{18}F-FLT$ uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model(2009)
Authors: Lieselot Brepoels, Sigrid Stroobants, Gregor Verhoef, Tjibbe De Groot, Luc Mortelmans, Christiane De Wolf-Peeters
Pages: 1102 - 1109 - Integrated PET/CT in the staging of nonsmall cell lung cancer(2009)
Authors: W. De Wever, Sigrid Stroobants, J. Coolen, Verschakelen J.A.
Pages: 201 - 212
Patents
1 - 3 of 3